Cormorant Asset Management, LP

Holdings History for Nektar Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NKTR)

Symbol: NKTR on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
30 Jun 2021			-0.01%	$0	0	-20,000	-100%	$42.28	Q2 2021
31 Mar 2021		0.01%	-0.01%	$400,000	20,000	-20,000	-50%	$20.00	Q1 2021
31 Dec 2020		0.02%	-0%	$680,000	40,000	-10,000	-20%	$17.00	Q4 2020
30 Sep 2020		0.04%	-0.05%	$830,000	50,000	-75,000	-60%	$16.60	Q3 2020
30 Jun 2020		0.13%	-0.03%	$2,895,000	125,000	-25,000	-17%	$23.16	Q2 2020
31 Mar 2020		0.15%	-0.05%	$2,678,000	150,000	-50,000	-25%	$17.85	Q1 2020
31 Dec 2019		0.19%	-0.56%	$4,317,000	200,000	-588,800	-75%	$21.58	Q4 2019
30 Sep 2019		1%	+0.51%	$14,368,000	788,800	+388,800	+97%	$18.22	Q3 2019
30 Jun 2019		0.9%	-0.23%	$14,232,000	400,000	-100,000	-20%	$35.58	Q2 2019
31 Mar 2019		1.2%	-0.11%	$16,800,000	500,000	-47,000	-8.6%	$33.60	Q1 2019
31 Mar 2019	call		-6.3%	$0	0	-250,000	-100%	$42.28	Q1 2019
31 Dec 2018		1.6%	-2.5%	$17,980,000	547,000	-823,000	-60%	$32.87	Q4 2018
31 Dec 2018	call	6.3%	-27%	$8,218,000	250,000	-1,078,400	-81%	$32.87	Q4 2018
30 Sep 2018		6%	-0.57%	$83,515,000	1,370,000	-130,000	-8.7%	$60.96	Q3 2018
30 Sep 2018	call	56%	-21%	$80,979,000	1,328,400	-500,000	-27%	$60.96	Q3 2018
30 Jun 2018		5.9%	-4.2%	$73,245,000	1,500,000	-1,063,200	-41%	$48.83	Q2 2018
30 Jun 2018	call	84%	+14%	$89,281,000	1,828,400	+297,500	+19%	$48.83	Q2 2018
31 Mar 2018		24%	+5.2%	$272,366,000	2,563,200	+565,500	+28%	$106.26	Q1 2018
31 Mar 2018	call	87%	+44%	$162,673,000	1,530,900	+780,900	+104%	$106.26	Q1 2018
31 Dec 2017		14%	+14%	$119,303,000	1,997,700	+1,997,700	NEW	$59.72	Q4 2017
31 Dec 2017	call	48%	+48%	$44,790,000	750,000	+750,000	NEW	$59.72	Q4 2017
30 Sep 2016			-4.1%	$0	0	-2,022,879	-100%	$42.28	Q3 2016
30 Jun 2016		4.1%	+0.05%	$28,786,000	2,022,879	+22,879	+1.1%	$14.23	Q2 2016
31 Mar 2016		4.1%	+2.6%	$27,500,000	2,000,000	+1,234,844	+161%	$13.75	Q1 2016
31 Dec 2015		1.5%	+0.74%	$12,893,000	765,156	+367,656	+92%	$16.85	Q4 2015
30 Sep 2015		0.7%	0%	$4,357,000	397,500	0		$10.96	Q3 2015
30 Jun 2015		0.66%	0%	$4,973,000	397,500	0		$12.51	Q2 2015
31 Mar 2015		0.68%	-0.09%	$4,373,000	397,500	-52,500	-12%	$11.00	Q1 2015
31 Dec 2014		1.1%	0%	$6,975,000	450,000	0		$15.50	Q4 2014
30 Sep 2014		1.1%	+1.1%	$5,432,000	450,000	+450,000	NEW	$12.07	Q3 2014

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.